Medsafe approves Janssen Covid-19 Vaccine in New Zealand

Medsafe approves Janssen Covid-19 Vaccine in New Zealand

Help speed up our reporting and keep independent local Journalism going. You might be able to donate to us so we can inform and share the latest stories that matter faster.

Donatearrow

New Zealand's medicines regulator, Medsafe, approved the Janssen Covid-19 Vaccine on Wednesday.

The Vaccine was given provisional approval by the regulator, which is developed by Janssen — the pharmaceutical unit of Johnson & Johnson.

It will be for use in individuals from 18 years of age and older.

Once provisional approval is given, advice from Ministry of Health officials will then be sent to the Government, who will make decisions around its use.

The Vaccine is safe and effective and will be used as a plan B in certain circumstances if, by chance, Pfizer/BioNTech runs out of stock or has a production issue.

Approval went to Medsafe in April, but additional data was sought as a precaution.

Image: SUPPLIED/Shutterstock.com

If you liked this publication, please consider donating to thisquality. Fund trustworthy news from official government and independent newswires around New Zealand.

Donatearrow

COVID-19 Coverage

Alert Level 3
*Northland, Auckland, Waikato

Alert Level 2
*Rest of New Zealand

*Button below directs to the government Unite Against COVID-19 website.

If you liked this publication, please consider donating to thisquality. Fund trustworthy news from official government and independent newswires around New Zealand.

Donatearrow
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments